950200 — Psomagen Balance Sheet
0.000.00%
- KR₩66bn
- KR₩65bn
- $32.01m
Annual balance sheet for Psomagen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 25.6 | 16.6 | 11.7 | 8.55 | 8 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3.59 | 5.46 | 6.88 | 4.81 | 5.43 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 31.4 | 24.8 | 22.4 | 17.6 | 18.3 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6.64 | 7.45 | 7.18 | 8.85 | 13.2 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 46.5 | 41.8 | 38.8 | 34.6 | 37.7 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 8.77 | 9.05 | 7.65 | 6.87 | 11.3 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 12.3 | 13 | 10.7 | 9.6 | 16.8 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 34.2 | 28.8 | 28.2 | 25 | 20.9 |
Total Liabilities & Shareholders' Equity | 46.5 | 41.8 | 38.8 | 34.6 | 37.7 |
Total Common Shares Outstanding |